Pneumococcal Carriage
0
Pipeline Programs
3
Companies
2
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Sharp TherapeuticsPA - Pittsburgh
2 programsOropharyngealN/A
Post Pandemic Pneumococcal Carriage Among Children and AdultsN/A
Merck & Co.RAHWAY, NJ
2 programsOropharyngealN/A
Post Pandemic Pneumococcal Carriage Among Children and AdultsN/A
MSDIreland - Ballydine
2 programsOropharyngealN/A1 trial
Post Pandemic Pneumococcal Carriage Among Children and AdultsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
MSDOropharyngeal
MSDPost Pandemic Pneumococcal Carriage Among Children and Adults
Clinical Trials (2)
Total enrollment: 960 patients across 2 trials
Pneumococcal Carriage Duration
Start: Jul 2026Est. completion: Jul 202760 patients
N/ARecruiting
Post Pandemic Pneumococcal Carriage Among Children and Adults
Start: Jun 2024Est. completion: Mar 2026900 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 960 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.